William Demant Holding AS (WDH):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:William Demant Holding AS (WDH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7177
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
William Demant Holding AS (WDH) is a provider of hearing healthcare solutions that develops, manufactures and distributes products designed to aid people with hearing loss. The company offers hearing devices and implants, diagnostic instruments and personal communication devices. Its product portfolio includes hearing aids and fitting systems, hearing implants, audiometers, tympanometers, assistive listening devices, wireless sound systems, sound field systems and sound systems for larger premises. The company markets its products through its own retail chain, direct sales force, e-commerce channels and third-party distributors. The company and its subsidiaries operate in Europe, North America, Oceania and Asia-Pacific. WDH is headquartered in Smorum, Denmark.

William Demant Holding AS (WDH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
William Demant Holding AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
William Demant Holding AS, Medical Equipment Deals By Type, 2012 to YTD 2018 6
William Demant Holding AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
William Demant Holding AS, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
William Demant Holding AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
William Demant Holding AS, Medical Equipment, Deal Details 10
Partnerships 10
Koninklijke Philips Enters into Licensing Agreement with William Demant 10
Oticon Enters into Licensing Agreement with Ceva 11
Acquisition 12
Amplifon May Acquire AudioNova International 12
William Demant Acquires Additional 40.63% Stake in Audika 14
Amplifon Acquires Audika Italia for USD10 Million 16
William Demant To Acquire Neurelec From Mxm For US$74 Million 17
William Demant Holding AS – Key Competitors 18
William Demant Holding AS – Key Employees 19
William Demant Holding AS – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 23
Financial Announcements 23
Aug 15, 2018: William Demant Holding: Interim report 2018 23
May 08, 2018: William Demant: Interim Management Statement covering the period year-to-date 24
Feb 22, 2018: William Demant: Annual Report 2017 27
Aug 14, 2017: William Demant Holding: Interim Report 2017 28
Feb 23, 2017: William Demant Holding: Annual Report 2016 29
Corporate Communications 30
Feb 23, 2017: Management change in William Demant Holding 30
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
William Demant Holding AS, Medical Equipment, Key Facts, 2017 2
William Demant Holding AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
William Demant Holding AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
William Demant Holding AS, Medical Equipment Deals By Type, 2012 to YTD 2018 6
William Demant Holding AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
William Demant Holding AS, Deals By Market, 2012 to YTD 2018 8
William Demant Holding AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Koninklijke Philips Enters into Licensing Agreement with William Demant 10
Oticon Enters into Licensing Agreement with Ceva 11
Amplifon May Acquire AudioNova International 12
William Demant Acquires Additional 40.63% Stake in Audika 14
Amplifon Acquires Audika Italia for USD10 Million 16
William Demant To Acquire Neurelec From Mxm For US$74 Million 17
William Demant Holding AS, Key Competitors 18
William Demant Holding AS, Key Employees 19
William Demant Holding AS, Subsidiaries 20

List of Figures
William Demant Holding AS, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
William Demant Holding AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
William Demant Holding AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
William Demant Holding AS, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
William Demant Holding AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
William Demant Holding AS, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
William Demant Holding AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
William Demant Holding AS, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[William Demant Holding AS (WDH):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Societe Generale Private Banking:企業の戦略・SWOT・財務分析
    Societe Generale Private Banking - Strategy, SWOT and Corporate Finance Report Summary Societe Generale Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • CollPlant Ltd:医療機器:M&Aディール及び事業提携情報
    Summary CollPlant Ltd (CollPlant) is a regenerative medicine company that develops and commercializes tissue repair products. The company’s product categories include orthobiologics, wound care, and pipeline products. Its orthobiologics products comprise VergenixSTR and VergenixBVF. CollPlant’s woun …
  • Tsumura & Co.:企業の戦略・SWOT・財務分析
    Tsumura & Co. - Strategy, SWOT and Corporate Finance Report Summary Tsumura & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Silence Therapeutics Plc (SLN)-製薬・医療分野:企業M&A・提携分析
    Summary Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a research and development company that develops and delivers RNA interference therapeutics for the treatment of serious diseases. The company's pipeline products include Atu027 and Atu111. Its Atu027 is developed for …
  • Medigen Biotechnology Corp (3176)-製薬・医療分野:企業M&A・提携分析
    Summary Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company’s pro …
  • Bel Fuse, Inc.:企業の戦略・SWOT・財務情報
    Bel Fuse, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bel Fuse, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Humana Inc.:企業の戦略・SWOT・財務情報
    Humana Inc. - Strategy, SWOT and Corporate Finance Report Summary Humana Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Feldan Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Feldan Therapeutics Inc (Feldan), formerly Feldan Bio Inc, is a biotechnology company with focus on the discovery, development, manufacture and marketing of recombinant proteins. The company developed a peptide-based technology platform, the Feldan Shuttle for intracellular delivery of prote …
  • Russian Aircraft Corporation MiG JSC:企業の戦略・SWOT・財務情報
    Russian Aircraft Corporation MiG JSC - Strategy, SWOT and Corporate Finance Report Summary Russian Aircraft Corporation MiG JSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • bet-at-home.com AG (ACX):企業の財務・戦略的SWOT分析
    bet-at-home.com AG (ACX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Stericycle, Inc. (SRCL):企業の財務・戦略的SWOT分析
    Stericycle, Inc. (SRCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • ANI Pharmaceuticals Inc (ANIP):製薬・医療:M&Aディール及び事業提携情報
    Summary ANI Pharmaceuticals Inc (ANI) formerly BioSante Pharmaceuticals Inc, is a specialty pharmaceutical company that develops, manufactures and markets pharmaceuticals. The company’s product portfolio encompasses generic and branded tablets indicated for ulcerative colitis; osteoarthritis; rheuma …
  • Echo Therapeutics Inc (ECTE)-医療機器分野:企業M&A・提携分析
    Summary Echo Therapeutics Inc (Echo Therapeutics) is a medical device and a specialty pharmaceutical company, which develops wireless continuous glucose monitoring (CGM) system. Its product portfolio includes Continuous Glucose Monitoring, which is a CGM System, a skin preparation device, transderma …
  • The US Oncology Network:企業の戦略的SWOT分析
    The US Oncology Network - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Total SA (FP)-石油・ガス分野:企業M&A・提携分析
    Summary Total S.A. (Total) is an integrated global oil and gas company that produces, refines and markets oil, and also manufactures petrochemicals. It carries out drilling, oil and gas production, processing, transportation, refining and petrochemical production, storage and distribution of petrole …
  • Subex Ltd (SUBEX):企業の財務・戦略的SWOT分析
    Subex Ltd (SUBEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • American Water Works Co Inc (AWK):企業の財務・戦略的SWOT分析
    Summary American Water Works Co Inc (AWW) is a utility company that offers fire protection and sanitation services. The company's services include water and wastewater services, military services, municipal and industrial contract, residual and home owner services. Its home owner services include wa …
  • NuVasive Inc (NUVA):企業の財務・戦略的SWOT分析
    NuVasive Inc (NUVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Nanolek:製薬・医療:M&Aディール及び事業提携情報
    Summary Nanolek is a drug development company that offers production of import-substituting and novel pharmaceuticals. The company’s product portfolio includes vaccines, drugs for treatment of leukemias, breast cancer, brain cancer, stomach and ovarian cancer, colorectal cancer, HIV infection and ot …
  • NextEra Energy Resources LLC:電力:M&Aディール及び事業提携情報
    Summary NextEra Energy Resources, LLC (NEER), a subsidiary of NextEra Energy, Inc., is a diversified clean energy company and is one of the largest wholesale generators of electric power in the US. The company, together with its subsidiaries owns, develops, constructs, manages and operates electrici …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆